116 related articles for article (PubMed ID: 9703781)
21. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Suchanek KM; May FJ; Robinson JA; Lee WJ; Holman NA; Monteith GR; Roberts-Thomson SJ
Mol Carcinog; 2002 Aug; 34(4):165-71. PubMed ID: 12203367
[TBL] [Abstract][Full Text] [Related]
23. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
24. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
26. Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth.
Silberstein GB; Dressler GR; Van Horn K
Oncogene; 2002 Feb; 21(7):1009-16. PubMed ID: 11850818
[TBL] [Abstract][Full Text] [Related]
27. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
28. Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas.
Cassoni P; Sapino A; Papotti M; Bussolati G
Int J Cancer; 1996 Jun; 66(6):817-20. PubMed ID: 8647655
[TBL] [Abstract][Full Text] [Related]
29. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors.
Cassoni P; Sapino A; Stella A; Fortunati N; Bussolati G
Int J Cancer; 1998 Aug; 77(5):695-700. PubMed ID: 9688301
[TBL] [Abstract][Full Text] [Related]
30. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
32. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
[TBL] [Abstract][Full Text] [Related]
33. Oxytocin does not induce a rise in intracellular free calcium in human breast cancer cells.
Fay MJ; Du J; Longo KA; North WG
Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):115-28. PubMed ID: 10461679
[TBL] [Abstract][Full Text] [Related]
34. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
35. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
37. Demonstration of functional oxytocin receptors in human breast Hs578T cells and their up-regulation through a protein kinase C-dependent pathway.
Copland JA; Jeng YJ; Strakova Z; Ives KL; Hellmich MR; Soloff MS
Endocrinology; 1999 May; 140(5):2258-67. PubMed ID: 10218979
[TBL] [Abstract][Full Text] [Related]
38. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
39. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol.
Hardwick M; Fertikh D; Culty M; Li H; Vidic B; Papadopoulos V
Cancer Res; 1999 Feb; 59(4):831-42. PubMed ID: 10029072
[TBL] [Abstract][Full Text] [Related]
40. Oxytocin-induced phasic and tonic contractions are modulated by the contractile machinery rather than the quantity of oxytocin receptor.
Kawamata M; Tonomura Y; Kimura T; Sugimoto Y; Yanagisawa T; Nishimori K
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E992-9. PubMed ID: 17148756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
